Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: Grand View Research | PRODUCT CODE: 1888549

Cover Image

PUBLISHER: Grand View Research | PRODUCT CODE: 1888549

Middle East Synthetic Biology Market Size, Share & Trends Analysis Report By Product, By Technology, By Application, By End Use, By Country, And Segment Forecasts, 2025 - 2033

PUBLISHED:
PAGES: 150 Pages
DELIVERY TIME: 2-10 business days
SELECT AN OPTION
Unprintable PDF & Excel (Single User License)
USD 5950
Printable PDF & Excel (5-User License)
USD 6950
Printable PDF & Excel (Enterprise License)
USD 8950

Add to Cart

Middle East Synthetic Biology Market Summary

The Middle East synthetic biology market size was estimated at USD 223.3 million in 2024 and is expected to reach USD 705.2 million by 2033, growing at a CAGR of 13.47% from 2025 to 2033, Growing biotechnology investments, demand for novel treatments, and encouraging government programs to develop the area's synthetic biology capabilities are the main drivers of this expansion.

Middle East Synthetic Biology Market Report Segmentation

This report forecasts revenue growth and provides an analysis on the latest trends in each of the sub-segments from 2021 to 2033. For this report, Grand View Research has segmented the Middle East synthetic biology market on the basis of product, technology, application end use, and country:

  • Product Outlook (Revenue, USD Million, 2021 - 2033)
  • Oligonucleotide/Oligo Pools and Synthetic DNA
  • Enzymes
  • Cloning Technologies Kits
  • Xeno-Nucleic Acids
  • Chassis Organism
  • Technology Outlook (Revenue, USD Million, 2021 - 2033)
  • NGS Technology
  • PCR Technology
  • Genome Editing Technology
  • Bioprocessing Technology
  • Other Technologies
  • Application Outlook (Revenue, USD Million, 2021 - 2033)
  • Healthcare
  • Clinical
    • Bio/Pharmaceuticals
    • Diagnostics
  • Non-Clinical
  • Non-healthcare
  • Biotech Crops
  • Specialty Chemicals
  • Bio-fuels
  • Others
  • End Use Outlook (Revenue, USD Million, 2021 - 2033)
  • Biotechnology and Pharmaceutical companies
  • Academic and Research Institutes
  • Others
  • Country Outlook (Revenue, USD Million, 2021 - 2033)
  • Middle East
  • Saudi Arabia
  • UAE
  • Kuwait
  • Qatar
  • Oman
  • Rest of Middle East
Product Code: GVR-4-68040-792-0

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definitions
    • 1.2.1. Product Segment
    • 1.2.2. Technology Segment
    • 1.2.3. Application Segment
    • 1.2.4. End Use Segment
  • 1.3. Information Analysis
    • 1.3.1. Market Formulation & Data Visualization
  • 1.4. Data Validation & Publishing
  • 1.5. Information Procurement
    • 1.5.1. Primary Research
  • 1.6. Information or Data Analysis
  • 1.7. Market Formulation & Validation
  • 1.8. Market Model
  • 1.9. Objectives
    • 1.9.1. Objective 1
    • 1.9.2. Objective 2

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Market Trends and Outlook
    • 3.2.1. Market Dynamics
      • 3.2.1.1. Technical Advancements
      • 3.2.1.2. Academic & Research Expansion
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. Biosafety and Biosecurity Issue
      • 3.2.2.2. Ethical Issues and Unintended Consequences
  • 3.3. Industry Analysis Tools
    • 3.3.1. PESTLE Analysis
    • 3.3.2. Porter's Five Forces Analysis

Chapter 4. Product Business Analysis

  • 4.1. Product Segment Dashboard
  • 4.2. Middle East Synthetic Biology Market: Product Movement Analysis
  • 4.3. Middle East Synthetic Biology Market Size & Trend Analysis, by Product, 2021 to 2033 (USD Million)
  • 4.4. Oligonucleotide/Oligo pools and Synthetic DNA
    • 4.4.1. Oligonucleotide/Oligo pools and Synthetic DNA Market, 2021 - 2033 (USD Million)
  • 4.5. Enzymes
    • 4.5.1. Enzymes Market, 2021 - 2033 (USD Million)
  • 4.6. Cloning Technologies Kits
    • 4.6.1. Cloning Technologies Kits Market, 2021 - 2033 (USD Million)
  • 4.7. Xeno-nucleic Acids
    • 4.7.1. Xeno-nucleic Acids Market, 2021 - 2033 (USD Million)
  • 4.8. Chassis Organism
    • 4.8.1. Chassis Organism Market, 2021 - 2033 (USD Million)

Chapter 5. Technology Business Analysis

  • 5.1. Technology Segment Dashboard
  • 5.2. Middle East Synthetic Biology Market: Technology Movement Analysis
  • 5.3. Middle East Synthetic Biology Market Size & Trend Analysis, by Technology, 2021 to 2033 (USD Million)
  • 5.4. PCR
    • 5.4.1. PCR Market, 2021 - 2033 (USD Million)
  • 5.5. Genome Editing
    • 5.5.1. Genome Editing Market, 2021 - 2033 (USD Million)
  • 5.6. NGS
    • 5.6.1. NGS Market, 2021 - 2033 (USD Million)
  • 5.7. Bioprocessing Technology
    • 5.7.1. Bioprocessing Technology Market, 2021 - 2033 (USD Million)
  • 5.8. Others
    • 5.8.1. Others Market, 2021 - 2033 (USD Million)

Chapter 6. Application Business Analysis

  • 6.1. Application Segment Dashboard
  • 6.2. Middle East Synthetic Biology Market: Application Movement Analysis
  • 6.3. Middle East Synthetic Biology Market Size & Trend Analysis, by Application, 2021 to 2033 (USD Million)
  • 6.4. Synthetic Biology Market: Technology Movement Analysis
  • 6.5. Healthcare
    • 6.5.1. Healthcare Market, 2021 - 2033 (USD Million)
    • 6.5.2. Clinical
      • 6.5.2.1. Clinical Market, 2021 - 2033 (USD Million)
      • 6.5.2.2. Bio/Pharmaceuticals
        • 6.5.2.2.1. Bio/Pharmaceuticals Market, 2021 - 2033 (USD Million)
      • 6.5.2.3. Diagnostics
        • 6.5.2.3.1. Diagnostics Market, 2021 - 2033 (USD Million)
    • 6.5.3. Non-Clinical
      • 6.5.3.1. Non-Clinical Market, 2021 - 2033 (USD Million)
  • 6.6. Non-Healthcare
    • 6.6.1. Non-Healthcare Market, 2021 - 2033 (USD Million)
    • 6.6.2. Biotech Crops
      • 6.6.2.1. Biotech Crops Market, 2021 - 2033 (USD Million)
    • 6.6.3. Specialty Chemicals
      • 6.6.3.1. Specialty Chemicals Market, 2021 - 2033 (USD Million)
    • 6.6.4. Bio-Fuels
      • 6.6.4.1. Bio-Fuels Market, 2021 - 2033 (USD Million)
    • 6.6.5. Others
      • 6.6.5.1. Others Market, 2021 - 2033 (USD Million)

Chapter 7. End Use Business Analysis

  • 7.1. End Use Segment Dashboard
  • 7.2. Middle East Synthetic Biology Market: End Use Movement Analysis
  • 7.3. Middle East Synthetic Biology Market Size & Trend Analysis, by End Use, 2021 to 2033 (USD Million)
  • 7.4. Biotechnology and Pharmaceutical Companies
    • 7.4.1. Biotechnology and Pharmaceutical Companies Market, 2021 - 2033 (USD Million)
  • 7.5. Academic & Research Institutes
    • 7.5.1. Academic & Research Institutes Market, 2021 - 2033 (USD Million)
  • 7.6. Others
    • 7.6.1. Others Market, 2021 - 2033 (USD Million)

Chapter 8. Country Business Analysis

  • 8.1. Country Dashboard
  • 8.2. Market Size & Forecasts and Trend Analysis, 2021 to 2033
  • 8.3. Middle East
    • 8.3.1. Middle East Synthetic Biology Market, 2021 - 2033 (USD Million)
    • 8.3.2. Qatar
      • 8.3.2.1. Key Country Dynamics
      • 8.3.2.2. Competitive Scenario
      • 8.3.2.3. Regulatory Framework
      • 8.3.2.4. Qatar Synthetic Biology Market, 2021 - 2033 (USD Million)
    • 8.3.3. Saudi Arabia
      • 8.3.3.1. Key Country Dynamics
      • 8.3.3.2. Competitive Scenario
      • 8.3.3.3. Regulatory Framework
      • 8.3.3.4. Saudi Arabia Synthetic Biology Market, 2021 - 2033 (USD Million)
    • 8.3.4. UAE
      • 8.3.4.1. Key Country Dynamics
      • 8.3.4.2. Competitive Scenario
      • 8.3.4.3. Regulatory Framework
      • 8.3.4.4. UAE Synthetic Biology Market, 2021 - 2033 (USD Million)
    • 8.3.5. Kuwait
      • 8.3.5.1. Key Country Dynamics
      • 8.3.5.2. Competitive Scenario
      • 8.3.5.3. Regulatory Framework
      • 8.3.5.4. Kuwait Synthetic Biology Market, 2021 - 2033 (USD Million)
    • 8.3.6. Oman
      • 8.3.6.1. Key Country Dynamics
      • 8.3.6.2. Competitive Scenario
      • 8.3.6.3. Regulatory Framework
      • 8.3.6.4. Oman Synthetic Biology Market, 2021 - 2033 (USD Million)

Chapter 9. Competitive Landscape

  • 9.1. Participant Categorization
  • 9.2. Strategy Mapping
  • 9.3. Company Market Position Analysis, 2024
  • 9.4. Participant's Overview
    • 9.4.1. Bota Biosciences Inc.
      • 9.4.1.1. Overview
      • 9.4.1.2. Financial Performance
      • 9.4.1.3. Product Benchmarking
      • 9.4.1.4. Strategic Initiatives
    • 9.4.2. Codexis, Inc.
      • 9.4.2.1. Overview
      • 9.4.2.2. Financial Performance
      • 9.4.2.3. Product Benchmarking
      • 9.4.2.4. Strategic Initiatives
    • 9.4.3. Creative Biogene
      • 9.4.3.1. Overview
      • 9.4.3.2. Financial Performance
      • 9.4.3.3. Product Benchmarking
      • 9.4.3.4. Strategic Initiatives
    • 9.4.4. Creative Enzymes
      • 9.4.4.1. Overview
      • 9.4.4.2. Financial Performance
      • 9.4.4.3. Product Benchmarking
      • 9.4.4.4. Strategic Initiatives
    • 9.4.5. Enbiotix, Inc.
      • 9.4.5.1. Overview
      • 9.4.5.2. Financial Performance
      • 9.4.5.3. Product Benchmarking
      • 9.4.5.4. Strategic Initiatives
    • 9.4.6. Illumina, Inc.
      • 9.4.6.1. Overview
      • 9.4.6.2. Financial Performance
      • 9.4.6.3. Product Benchmarking
      • 9.4.6.4. Strategic Initiatives
    • 9.4.7. Merck KGaA
      • 9.4.7.1. Overview
      • 9.4.7.2. Financial Performance
      • 9.4.7.3. Product Benchmarking
      • 9.4.7.4. Strategic Initiatives
    • 9.4.8. New England Biolabs
      • 9.4.8.1. Overview
      • 9.4.8.2. Financial Performance
      • 9.4.8.3. Product Benchmarking
      • 9.4.8.4. Strategic Initiatives
    • 9.4.9. Eurofins Scientific
      • 9.4.9.1. Overview
      • 9.4.9.2. Financial Performance
      • 9.4.9.3. Product Benchmarking
      • 9.4.9.4. Strategic Initiatives
    • 9.4.10. Novozymes
      • 9.4.10.1. Overview
      • 9.4.10.2. Financial Performance
      • 9.4.10.3. Product Benchmarking
      • 9.4.10.4. Strategic Initiatives
    • 9.4.11. Pareto Bio, Inc.
      • 9.4.11.1. Overview
      • 9.4.11.2. Financial Performance
      • 9.4.11.3. Product Benchmarking
      • 9.4.11.4. Strategic Initiatives
    • 9.4.12. Scarab Genomics, Inc.
      • 9.4.12.1. Overview
      • 9.4.12.2. Financial Performance
      • 9.4.12.3. Product Benchmarking
      • 9.4.12.4. Strategic Initiatives
    • 9.4.13. Synthego
      • 9.4.13.1. Overview
      • 9.4.13.2. Financial Performance
      • 9.4.13.3. Product Benchmarking
      • 9.4.13.4. Strategic Initiatives
    • 9.4.14. Synthetic Genomics Inc.
      • 9.4.14.1. Overview
      • 9.4.14.2. Financial Performance
      • 9.4.14.3. Product Benchmarking
      • 9.4.14.4. Strategic Initiatives
    • 9.4.15. Thermo Fisher Scientific, Inc.
      • 9.4.15.1. Overview
      • 9.4.15.2. Financial Performance
      • 9.4.15.3. Product Benchmarking
      • 9.4.15.4. Strategic Initiatives
Product Code: GVR-4-68040-792-0

List of Tables

  • Table 1 List of Secondary Sources
  • Table 2 List of Abbreviations
  • Table 3 Middle East Synthetic Biology Market, by Product, 2021 - 2033 (USD Million)
  • Table 4 Middle East Synthetic Biology Market, by Technology, 2021 - 2033 (USD Million)
  • Table 5 Middle East Synthetic Biology Market, by Application, 2021 - 2033 (USD Million)
  • Table 6 Middle East Synthetic Biology Market, End Use, 2021 - 2033 (USD Million)
  • Table 7 Middle East Synthetic Biology Market, by Country, 2021 - 2033 (USD Million)
  • Table 8 Qatar Synthetic Biology Market, by Product, 2021 - 2033 (USD Million)
  • Table 9 Qatar Africa Synthetic Biology Market, by Technology, 2021 - 2033 (USD Million)
  • Table 10 Qatar Africa Synthetic Biology Market, by Application, 2021 - 2033 (USD Million)
  • Table 11 Qatar Africa Synthetic Biology Market, End Use, 2021 - 2033 (USD Million)
  • Table 12 Saudi Arabia Synthetic Biology Market, by Product, 2021 - 2033 (USD Million)
  • Table 13 Saudi Arabia Synthetic Biology Market, by Technology, 2021 - 2033 (USD Million)
  • Table 14 Saudi Arabia Synthetic Biology Market, by Application, 2021 - 2033 (USD Million)
  • Table 15 Saudi Arabia Synthetic Biology Market, End Use, 2021 - 2033 (USD Million)
  • Table 16 UAE Synthetic Biology Market, by Product, 2021 - 2033 (USD Million)
  • Table 17 UAE Synthetic Biology Market, by Technology, 2021 - 2033 (USD Million)
  • Table 18 UAE Synthetic Biology Market, by Application, 2021 - 2033 (USD Million)
  • Table 19 UAE Synthetic Biology Market, End Use, 2021 - 2033 (USD Million)
  • Table 20 Kuwait Synthetic Biology Market, by Product, 2021 - 2033 (USD Million)
  • Table 21 Kuwait Synthetic Biology Market, by Technology, 2021 - 2033 (USD Million)
  • Table 22 Kuwait Synthetic Biology Market, by Application, 2021 - 2033 (USD Million)
  • Table 23 Kuwait Synthetic Biology Market, End Use, 2021 - 2033 (USD Million)
  • Table 24 Oman Synthetic Biology Market, by Product, 2021 - 2033 (USD Million)
  • Table 25 Oman Synthetic Biology Market, by Technology, 2021 - 2033 (USD Million)
  • Table 26 Oman Synthetic Biology Market, by Application, 2021 - 2033 (USD Million)
  • Table 27 Oman Synthetic Biology Market, End Use, 2021 - 2033 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Information Procurement
  • Fig. 3 Market Research Approaches
  • Fig. 4 Value Chain-Based Sizing & Forecasting
  • Fig. 5 Market Formulation & Validation
  • Fig. 6 Synthetic Biology Market Segmentation
  • Fig. 7 Market Snapshot, 2024
  • Fig. 8 Market Trends & Outlook
  • Fig. 9 Market Driver Relevance Analysis (Current & Future Impact)
  • Fig. 10 Market Restraint Relevance Analysis (Current & Future Impact)
  • Fig. 11 PESTLE Analysis
  • Fig. 12 Porter's Five Forces Analysis
  • Fig. 13 Middle East Synthetic Biology Market: Product Key Takeaways
  • Fig. 14 Middle East Synthetic Biology Market: Product Movement Analysis
  • Fig. 15 Middle East Synthetic Biology Market, for Oligonucleotide/Oligo pools and Synthetic DNA, 2021 - 2033 (USD Million)
  • Fig. 16 Middle East Synthetic Biology Market, for Enzymes, 2021 - 2033 (USD Million)
  • Fig. 17 Middle East Synthetic Biology Market, for Cloning Technologies Kits, 2021 - 2033 (USD Million)
  • Fig. 18 Middle East Synthetic Biology Market, for Xeno-nucleic acids, 2021 - 2033 (USD Million)
  • Fig. 19 Middle East Synthetic Biology Market, for Chassis Organism, 2021 - 2033 (USD Million)
  • Fig. 20 Middle East Synthetic Biology Market: Technology Key Takeaways
  • Fig. 21 Middle East Synthetic Biology Market: Technology Movement Analysis
  • Fig. 22 Middle East Synthetic Biology Market, for PCR, 2021 - 2033 (USD Million)
  • Fig. 23 Middle East Synthetic Biology Market, for Genome Editing, 2021 - 2033 (USD Million)
  • Fig. 24 Middle East Synthetic Biology Market, for NGS, 2021 - 2033 (USD Million)
  • Fig. 25 Middle East Synthetic Biology Market, for Bioprocessing Technology, 2021 - 2033 (USD Million)
  • Fig. 26 Middle East Synthetic Biology Market, for Others, 2021 - 2033 (USD Million)
  • Fig. 27 Middle East Synthetic Biology Market: Application Key Takeaways
  • Fig. 28 Middle East Synthetic Biology Market, Application Movement Analysis
  • Fig. 29 Middle East Synthetic Biology Market, for Healthcare, 2021 - 2033 (USD Million)
  • Fig. 30 Middle East Synthetic Biology Market, for Clinical, 2021 - 2033 (USD Million)
  • Fig. 31 Middle East Synthetic Biology Market, for Bio/Pharmaceuticals, 2021 - 2033 (USD Million)
  • Fig. 32 Middle East Synthetic Biology Market, for Diagnostics, 2021 - 2033 (USD Million)
  • Fig. 33 Middle East Synthetic Biology Market, for Non-Clinical, 2021 - 2033 (USD Million)
  • Fig. 34 Middle East Synthetic Biology Market, for Non-Healthcare, 2021 - 2033 (USD Million)
  • Fig. 35 Middle East Synthetic Biology Market, for Biotech Crops, 2021 - 2033 (USD Million)
  • Fig. 36 Middle East Synthetic Biology Market, for Specialty Chemicals, 2021 - 2033 (USD Million)
  • Fig. 37 Middle East Synthetic Biology Market, for Bio-fuels, 2021 - 2033 (USD Million)
  • Fig. 38 Middle East Synthetic Biology Market, for Others, 2021 - 2033 (USD Million)
  • Fig. 39 Middle East Synthetic Biology Market: End Use Movement Analysis
  • Fig. 40 Middle East Synthetic Biology Market, for Biotechnology and Pharmaceutical Companies, 2021 - 2033 (USD Million)
  • Fig. 41 Middle East Synthetic Biology Market, for Academic & Research Institutes, 2021 - 2033 (USD Million)
  • Fig. 42 Middle East Synthetic Biology Market, for Others, 2021 - 2033 (USD Million)
  • Fig. 43 Country Marketplace: Key Takeaways
  • Fig. 44 Country Outlook, 2024 & 2033
  • Fig. 45 Middle East and Africa Synthetic Biology Market, 2021 - 2033 (USD Million)
  • Fig. 46 Qatar Synthetic Biology Market, 2021 - 2033 (USD Million)
  • Fig. 47 Saudi Arabia Synthetic Biology Market, 2021 - 2033 (USD Million)
  • Fig. 48 UAE Synthetic Biology Market, 2021 - 2033 (USD Million)
  • Fig. 49 Kuwait Synthetic Biology Market, 2021 - 2033 (USD Million)
  • Fig. 50 Oman Synthetic Biology Market, 2021 - 2033 (USD Million)
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!